Prednisolone in HBsAg‐positive chronic active hepatitis: Histologic evaluation in a controlled prospective study
Pui C. Wu, Ching L. Lai, Kui C. Lam, Joana Ho – 1 November 1982 – To study the value of corticosteroids in HBsAg‐positive chronic active hepatitis, 18 pairs of liver histology comprising 36 liver biopsies from a prospective, randomized, controlled trial were evaluated. The median interval between the initial and follow‐up histology was 8 1/2 months in 8 patients given prednisolone and 8 1/4 months in 10 patients given placebo tablets.